Clorox Reports Q2 Fiscal Year 2018 Results; Raises EPS Outlook for Tax Reform

Go back to Clorox Reports Q2 Fiscal Year 2018 Results; Raises EPS Outlook for Tax Reform

Clorox (CLX) PT Lowered to $147 at BMO Capital

February 6, 2018 8:54 AM EST

BMO Capital lowered its price target on Clorox (NYSE: CLX) to $147.00 (from $150.00) while maintaining a Outperform rating.

... More

Buy Clorox (CLX) on Today's Weakness - BMO

February 2, 2018 11:10 AM EST

BMO Capital analyst Shannon Coyne is telling clients to buy Clorox (NYSE: CLX) on today's weakness.

Coyne commented, "CLX reported 2Q/18 adj. EPS of $1.77, beating Consensus/BMO of $1.23/$1.26, though quality was low ($0.61 benefit from a lower effective tax rate) and revenues light. Management raised... More

Clorox (CLX) Reports Q2 Revenue About In-Line with Views

February 2, 2018 6:33 AM EST

Clorox (NYSE: CLX) reported Q2 EPS of $1.77, $0.54 better than the analyst estimate of $1.23. Revenue for the quarter came in at $1.42 billion versus the consensus estimate of $1.43 billion.

Diluted EPS results reflect a benefit of 61 cents from a significantly lower... More